Skip to content

Clinical trials

Phase 1/2 Autoimmune Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 1/2 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20211
20221
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Not yet recruiting3
Active, not recruiting2
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Essen Biotech3
Shenzhen Geno-Immune Medical Institute2
Beijing Baylx Biotech Co., Ltd.1
Beijing GoBroad Hospital1
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1
Hebei Senlang Biotechnology Inc., Ltd.1
Sun Yat-sen University1
University of Illinois at Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases11
Lupus Erythematosus, Systemic3
Sjogren's Syndrome2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Arthritis, Rheumatoid1
Diabetes Mellitus, Type 21
Endocrine System Diseases1
Eye Diseases1
Eye Diseases, Hereditary1
Granulomatosis with Polyangiitis1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.